Article

Economic burden of kidney cancer eased by robotics

Adoption of robotic surgery for treatment of kidney cancer has led to a modest increase in the annual volume of partial nephrectomies but a substantial cost savings for care of chronic kidney disease, an economic analysis of a 6-year period suggests.

© 2025 MJH Life Sciences

All rights reserved.